Skip to main content
. 2011 Dec 2;6(12):e26783. doi: 10.1371/journal.pone.0026783

Table 6. Incremental Cost-Effectiveness Ratios ($/QALY) by Cohort Starting Age, Genotype 1 under Standard Treatment, Base Case Fibrosis Stage Distribution.

Men, Age 40 50 60 70
Do Nothing
FibroTest Only ED ED ED ED
FibroTest and Biopsy D D D D
FibroTest Rule In D D D ED
FibroTest Rule Out D D D D
Liver Biopsy Only D D D D
Immediate Treatment $12,100/QALY $14,800/QALY $19,900/QALY $31,600/QALY

(D: dominated, ED: Extended-Dominated by a combination of Do Nothing and Immediate Treatment).